We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+22.23%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$18.5B
AUM Growth
+$2.83B
Cap. Flow
+$342M
Cap. Flow %
1.85%
Top 10 Hldgs %
16.55%
Holding
2,427
New
891
Increased
366
Reduced
546
Closed
599

Top Buys

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$163M
2
CCL icon
Carnival Corporation Ltd
CCL
+$137M
3
RGEN icon
Repligen
RGEN
+$104M
4
BIIB icon
Biogen
BIIB
+$104M
5
ZTS icon
Zoetis
ZTS
+$91.9M

Sector Composition

Rank Sector Weight
1 Healthcare 28.24%
2 Consumer Discretionary 12.89%
3 Financials 10.77%
4 Technology 9.62%
5 Industrials 4.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CCAC.WS
1101
CALL
DELISTED
CITIC Capital Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary sh
CCAC.WS
$1.31M 0.01%
+124,998
New +$168K
CHE icon
1102
Chemed
CHE
$6.76B
$1.31M 0.01%
2,458
-14,694
-86% -$7.22M
SUZ icon
1103
Suzano
SUZ
$10.1B
$1.31M 0.01%
+117,092
New +$1.12M
BTG icon
1104
B2Gold
BTG
$5.16B
$1.3M 0.01%
+232,748
New +$1.42M
RETA
1105
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$1.3M 0.01%
10,516
+3,591
+52% +$472K
WAFD icon
1106
WaFd
WAFD
$2.69B
$1.29M 0.01%
50,252
-173,783
-78% -$4.13M
TREE icon
1107
LendingTree
TREE
$564M
$1.29M 0.01%
+4,711
New +$1.4M
EXK
1108
Endeavour Silver
EXK
$2.35B
$1.29M 0.01%
+255,504
New +$945K
AGC
1109
DELISTED
Altimeter Growth Corp
AGC
$1.29M 0.01%
+99,965
New +$1.28M
EFA icon
1110
CALL
iShares MSCI EAFE ETF
EFA
$76.8B
$1.28M 0.01%
17,600
-7,600
-30% -$520K
VNET
1111
VNET Group
VNET
$2.04B
$1.28M 0.01%
+36,995
New +$972K
ATKR icon
1112
Atkore
ATKR
$2.54B
$1.28M 0.01%
31,114
-116,271
-79% -$3.67M
BRBR icon
1113
BellRing Brands
BRBR
$1.52B
$1.28M 0.01%
+52,520
New +$1.14M
BL icon
1114
BlackLine
BL
$1.8B
$1.27M 0.01%
+9,564
New +$1.07M
ATH
1115
DELISTED
Athene Holding Ltd. Class A Common Shares
ATH
$1.27M 0.01%
29,546
-10,971
-27% -$434K
BB icon
1116
BlackBerry
BB
$4.93B
$1.27M 0.01%
192,055
-46,824
-20% -$277K
CPSR.WS
1117
CALL
DELISTED
Capstar Special Purpose Acquisition Corp. Warrants, each whole warrant exercisable for one share of
CPSR.WS
$1.27M 0.01%
+124,999
New +$124K
TSLX icon
1118
Sixth Street Specialty
TSLX
$1.63B
$1.27M 0.01%
61,059
-138,461
-69% -$2.63M
REGN icon
1119
Regeneron Pharmaceuticals
REGN
$69.9B
$1.27M 0.01%
+2,620
New +$1.41M
GDS icon
1120
GDS Holdings
GDS
$6.29B
$1.26M 0.01%
13,413
+9,305
+227% +$826K
EWBC icon
1121
East-West Bancorp
EWBC
$17.8B
$1.25M 0.01%
24,695
+10,317
+72% +$438K
HAE icon
1122
Haemonetics
HAE
$3.63B
$1.24M 0.01%
10,459
-76,452
-88% -$8.23M
T icon
1123
AT&T
T
$167B
$1.24M 0.01%
+57,174
New +$1.23M
JAZZ icon
1124
Jazz Pharmaceuticals
JAZZ
$16B
$1.24M 0.01%
+7,519
New +$1.12M
BYND icon
1125
Beyond Meat
BYND
$283M
$1.24M 0.01%
+9,916
New +$1.5M

Similar funds

Marshall Wace's Q4 2020 Portfolio in Review

As of Q4 2020, Marshall Wace held 2,427 positions worth $18.5B, up 18% from $15.6B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Marshall Wace's Q4 2020 filing shows 891 new, 366 increased, 546 reduced and 599 closed positions. Its largest new stake was Natera: 911,254 shares worth $90.7M. The largest sale was Alphabet (Google) Class A, an estimated $173M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Marshall Wace's largest Q4 2020 buy was Natera: 911,254 shares worth $90.7M.
  • Marshall Wace added most to Thermo Fisher Scientific in Q4 2020, an estimated $163M increase.
  • Marshall Wace's biggest Q4 2020 reduction was Alphabet (Google) Class A, cutting an estimated $173M.
  • Marshall Wace fully exited FedEx in Q4 2020, selling an estimated $69.6M.
  • Marshall Wace's ten largest holdings make up 17% of its $18.5B portfolio in Q4 2020.
  • Marshall Wace opened 891 new positions and closed 599 in Q4 2020.
  • Marshall Wace's portfolio value rose 18% quarter-over-quarter to $18.5B.

Based on Marshall Wace's 13F filing for Q4 2020, filed 16 Feb 2021.